Xenetic Biosciences, Inc. (XBIO) stock
XBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/3064% below fair value
$1.53−0.08 (-4.97%)
Close on Nov 18, 2026Market cap $3.59MP/E –Yield –
Xenetic Biosciences market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Xenetic Biosciences's market cap was $4.37M on Nov 11, 2026, against $4.06M a year earlier. Over the last 5 years it ranged from $3.35M to $17.27M, with a median of $6.16M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $4.37M | +30.7% |
| 2025 | Dec 31, 2025 | $3.35M | -45.6% |
| 2024 | Dec 31, 2024 | $6.15M | +16.4% |
| 2023 | Dec 29, 2023 | $5.29M | +29.5% |
| 2022 | Dec 30, 2022 | $4.08M | -76.4% |
| 2021 | Dec 31, 2021 | $17.27M | +34.4% |
| 2020 | Dec 31, 2020 | $12.84M | +58.3% |
| 2019 | Dec 31, 2019 | $8.11M | -47.4% |
| 2018 | Dec 31, 2018 | $15.42M | -7.8% |
| 2017 | Dec 29, 2017 | $16.73M | -53.1% |
| 2016 | Dec 30, 2016 | $35.64M | – |
See a number that looks wrong?